Hepatitis B Immune Globulin (HBIG) from China
HBIG is a human immune serum providing high-titer anti-HBs antibodies for post-exposure prophylaxis against hepatitis B virus. Classified in HTS 3002.12.0030 as human immune blood sera from HBV-vaccinated or recovered donors. It is essential for preventing mother-to-child transmission and needle-stick exposures.
Duty Rate — China → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Declare HBsAg titer (>50,000 IU/L) on invoice; FDA requires lot release protocol
• Use insulated shipping with temperature logs (-20°C to -80°C) to prevent denaturation